0 Commentaires
0 Parts
249 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Beyond Blood Sugar: SGLT2 Inhibitors and Their Cardiorenal Protective Effects in Diabetes ManagementFor individuals with Type 1 Diabetes and advanced Type 2 Diabetes, the foundation of treatment remains insulin, but the quality of life is being dramatically improved by new insulin analogues and novel delivery methods. The goal is to more closely mimic the body's natural physiological insulin response. Ultra-long-acting insulin analogues, such as insulin icodec, are being developed to allow...0 Commentaires 0 Parts 630 Vue 0 Aperçu
-
The GLP-1 Revolution: Highlighting the Impact of Incretin-Based Therapies on Metabolic HealthThe introduction of drugs acting on the Glucagon-Like Peptide-1 (GLP-1) pathway has fundamentally reshaped the landscape of the endocrinology therapeutic domain over the last decade. GLP-1 receptor agonists, such as Semaglutide and Dulaglutide, mimic the action of natural incretin hormones, stimulating insulin secretion, inhibiting glucagon release, and, crucially, slowing gastric emptying....0 Commentaires 0 Parts 667 Vue 0 Aperçu
-
Thyroid Function Test Market to Reach USD 3.10 Billion by 2033, Growing at a CAGR of 5.9% (2025–2033)Market Overview The global thyroid function test market size was valued at USD 1.85 billion in 2024 and is projected to grow from USD 1.96 billion in 2025 to USD 3.10 billion by 2033, growing at a CAGR of 5.90% during the forecast period (2025-2033). The global Thyroid Function Test market continues to evolve rapidly, driven by shifting consumer...0 Commentaires 0 Parts 1KB Vue 0 Aperçu